3.8 Review

The roles of aldo-keto reductases in steroid hormone action

Journal

DRUG NEWS & PERSPECTIVES
Volume 17, Issue 9, Pages 563-578

Publisher

PROUS SCIENCE, SAU-THOMSON REUTERS
DOI: 10.1358/dnp.2004.17.9.872570

Keywords

-

Funding

  1. NCI NIH HHS [R01 CA90744] Funding Source: Medline
  2. NIDDK NIH HHS [R01 DK47015] Funding Source: Medline

Ask authors/readers for more resources

dThe human aldo-keto reductase 1 C (AKR1C) isozymes are implicated in the pre-receptor regulation of steroid receptors, nuclear orphan receptors and membrane-bound ligand-gated ion channels. Human AKR members that may regulate the local concentration of steroid hormones include: AKR1C1, AKR1C2, AKR1C3, AKR1C4 and AKR1D1. Since, these enzymes are pluripotent, the physiological role for the human AKR1C isozymes is determined by their tissue-specific expression patterns and their substrate availability in target tissues. AKRs work in concert with short-chain dehydrogenases/reductases as switches to control ligand access to nuclear receptors. Consequently, they are potential targets in treating prostate cancer, breast cancer, endometriosis and endometrial cancer. (C) 2004 Prous Science. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available